Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vistagen Therapeutics Inc
(NQ:
VTGN
)
4.480
+0.030 (+0.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
153,524
Open
4.510
Bid (Size)
4.370 (1)
Ask (Size)
4.580 (1)
Prev. Close
4.450
Today's Range
4.390 - 4.580
52wk Range
1.620 - 24.71
Shares Outstanding
9,362,444
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present at Upcoming RBC Capital Markets Global Healthcare Conference
May 07, 2024
Via
Investor Brand Network
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From
Vistagen
Via
Business Wire
Performance
YTD
-13.01%
-13.01%
1 Month
-13.35%
-13.35%
3 Month
-5.29%
-5.29%
6 Month
+45.45%
+45.45%
1 Year
+11.61%
+11.61%
More News
Read More
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Reports Positive PH15 Data from Pilot Study Showing Psychomotor Impairment Improvement
April 25, 2024
Via
Investor Brand Network
Recap: Vistagen Therapeutics Q3 Earnings
February 13, 2024
Via
Benzinga
VistaGen Therapeutics's Earnings: A Preview
February 12, 2024
Via
Benzinga
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
April 25, 2024
From
Vistagen
Via
Business Wire
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
April 19, 2024
Via
InvestorPlace
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
April 09, 2024
Via
InvestorPlace
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation at Upcoming Anxiety and Depression Association Conference
April 09, 2024
Via
Investor Brand Network
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
April 09, 2024
From
Vistagen
Via
Business Wire
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Appointment of New VP of Translational Medicine
April 01, 2024
Via
Investor Brand Network
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
April 01, 2024
From
Vistagen
Via
Business Wire
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027
March 31, 2024
Via
InvestorPlace
InvestorNewsBreaks — Vistagen Therapeutics Inc.’s (NASDAQ: VTGN) Announces Participation at Upcoming Stifel 2024 Virtual CNS Days
March 11, 2024
Via
Investor Brand Network
Vistagen to Present at Stifel 2024 Virtual CNS Days
March 11, 2024
From
Vistagen
Via
Business Wire
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present at TD Cowen Conference
February 28, 2024
Via
Investor Brand Network
Vistagen to Present at TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
Vistagen
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
3 Revolutionary Biotech Stocks Poised for 10X Surge
February 19, 2024
Via
InvestorPlace
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
February 14, 2024
Via
InvestorPlace
InvestorNewsBreaks — Vistagen Therapeutics Inc.’s (NASDAQ: VTGN) Releases Q3 2024 Financial Report, Corporate Update
February 14, 2024
Via
Investor Brand Network
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
February 13, 2024
From
Vistagen
Via
Business Wire
3 Penny Stocks to Buy for the Next Bull Run: February 2024
February 07, 2024
Via
InvestorPlace
Earnings Scheduled For February 13, 2024
February 13, 2024
Via
Benzinga
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q3 Results, Conference Call
February 06, 2024
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.